Abiopharma

Suvanza is a Nevada public corporation and the survivor entity after plan of Merger with CenterSpan Communication Corporation which changed its focus from communication products to pharmaceutical products. All of the pharmaceutical business has been transferred into Suvanza, and the Company has moved from Oregon to Nevada through the traditional process of merger. The Company changed its name to Suvanza to meet name recognition goals. Suvanza received in return for stock: All of the assets of the new dermatology Drug Delivery System (pharmaceuticals) license. Three fully developed drugs. One fully developed drug with three indications, ready for governmental allowance and sale. Several additional drugs which are fully or almost fully ready to seek FDA clearance. No liabilities or contingent liabilities.

Additional info from OTC:
Suvanza is a Nevada public corporation and the survivor entity after plan of Merger with CenterSpan Communication Corporation which changed its focus from communication products to pharmaceutical products. All of the pharmaceutical business has been transferred into Suvanza, and the Company has moved from Oregon to Nevada through the traditional process of merger. The Company changed its name to Suvanza to meet name recognition goals. Suvanza received in return for stock: All of the assets of the new dermatology Drug Delivery System (pharmaceuticals) license. Three fully developed drugs. One fully developed drug with three indications, ready for governmental allowance and sale. Several additional drugs which are fully or almost fully ready to seek FDA clearance. No liabilities or contingent liabilities.